a b s t r a c t T-box genes are frequently expressed in dynamic patterns during animal development, but the mechanisms controlling expression of these genes are not well understood. The Caenorhabditis elegans T-box gene tbx-2 is essential for development of the ABa-derived pharyngeal muscles, specification of neural cell fate in the HSN/PHB lineage, and adaptation in olfactory neurons. The tbx-2 expression pattern is complex, and expression has been described in pharyngeal precursors and body wall muscles during embryogenesis, and amphid sensory neurons and pharyngeal neurons in adults. To examine mechanisms regulating tbx-2 gene expression, we performed an RNAi screen of transcription factor genes in strains containing a Ptbx-2::gfp reporter and identified the Nuclear Factor Y (NF-Y) complex as a negative regulator of tbx-2 expression. NF-Y is a heterotrimeric CCAAT-binding complex consisting of A-C subunits, and reduction of the NF-Y subunits nfya-1, nfyb-1, or nfyc-1 by RNAi or using mutants results in ectopic Ptbx-2::gfp expression in hypodermal seam cells and gut. Mutation of two CCAAT-boxes in the tbx-2 promoter results in a similar pattern of ectopic Ptbx-2::gfp expression, suggesting NF-Y directly represses the tbx-2 promoter. tbx-2 mRNA is moderately increased in nfya-1 null mutants, indicating NF-Y represses expression of endogenous tbx-2. Finally we identify and characterize a second-site mutation that enhances lethality of a temperature sensitive tbx-2 mutant and show that this mutation is a deletion in the nfyb-1 gene. Together, these results identify NF-Y as an important regulator of tbx-2 function in vivo.
Introduction
T-box transcription factors play essential roles in the development of all multicellular animals, where their functions include the specification of primary germ layers and the specification of cell fates during organogenesis [reviewed in (Naiche et al., 2005; Showell et al., 2004) ]. In humans, mutations in T-box genes have recently been implicated in a variety of congenital diseases and cancers, and, in most cases, the level of T-box gene expression is a crucial determinant of disease. For example, haploinsufficiency for the T-box genes TBX5, TBX3, TBX1, TBX22, and TBX19 results in Holt-Oram syndrome, Ulnar-Mammary syndrome, DiGeorge syndrome, cleft palate with ankyloglossia, and ACTH deficiency, respectively [reviewed in (Packham and Brook, 2003) ]. Conversely, overexpression of TBX2 and TBX3 is observed in a variety of cancers, including cancers of the breast, pancreas, ovary, and skin [reviewed in (Abrahams et al., 2010; Lu et al., 2010) ]. Because precise regulation of T-box gene expression is crucial for normal function, several recent studies have focused on identifying upstream regulators of mammalian T-box genes. These have identified Wnt/ß-catenin and BMP/Smad signaling pathways, the cell cycle regulators PML and E2F4, and the Nuclear Factor Y (NF-Y) complex as regulators of T-box gene expression (Martin et al., 2012; Renard et al., 2007; Smith et al., 2011; Teng et al., 2008; Zhang et al., 2011) .
We are characterizing mechanisms controlling T-box factor expression and activity in Caenorhabditis elegans and are focusing on the tbx-2 gene. TBX-2 is the sole C. elegans member of the Tbx2-subfamily of T-box factors, and it is most closely related to the human proteins TBX2 and TBX3 (Pocock et al., 2004; Roy Chowdhuri et al., 2006) . During embryogenesis tbx-2 is required for formation of pharyngeal muscles derived from the ABa blastomere and for specifying the fate and differentiation pattern of the HSN and PHB neurons, and null mutants exhibit larval lethality resulting from an inability to feed (Roy Chowdhuri et al., 2006; Singhvi et al., 2008; Smith and Mango, 2007) . tbx-2 also plays a role in neuronal plasticity, and viable non-null alleles have defects in adaptation to odorants and formation of dauer larvae (Miyahara et al., 2004) . tbx-2 null mutants arrest as L1 larvae shortly after hatching due to pharyngeal defects and an inability to feed (Roy Chowdhuri et al., 2006; Smith and Mango, 2007 Consistent with its diverse spatial and temporal functions, tbx-2 is expressed in a variety of tissues. tbx-2 expression has been examined at different developmental stages using gfp reporters (Roy Chowdhuri et al., 2006; Smith and Mango, 2007) , antibodies (Miyahara et al., 2004) , and by in situ hybridization [NEXTDB Ver. 4 .0, yk112c4, http://nematode.lab.nig.ac.jp/db/index. html; (Kohara, 2001) ]. These analyses indicate tbx-2 is expressed in a dynamic pattern, with strong expression in the developing pharynx during embryogenesis and expression in a subset of neurons from late embryogenesis through adulthood. tbx-2 expression outside the pharynx is repressed by LAG-1 and REF-1 components of the Notch signaling pathway, while expression in the pharynx is maintained by PHA-4/FoxA in a positive feedback loop (Smith and Mango, 2007) .
To identify additional mechanisms controlling tbx-2 expression, we performed an RNAi screen of transcription factor genes in which we looked for altered expression of a tbx-2::gfp reporter. We found that RNAi knockdown of the nfyc-1 subunit of the CCAAT-box binding factor NF-Y resulted in ectopic tbx-2::gfp expression in the seam cells and gut. nfyc-1 encodes one subunit of the heterotrimeric NF-Y transcription factor. We used a variety of genetic and molecular approaches that indicate the NF-Y complex containing the NFYA-1, NFYB-1 and NFYC-1 subunits directly targets the tbx-2 promoter and represses tbx-2 expression. Further, we found strong genetic interactions between a newly identified nfyb-1 mutant and a temperature sensitive tbx-2 mutant. Together, these results indicate NF-Y repression is crucial for tbx-2 function in vivo.
Materials and methods
Nematode handling, transformation, and strains C. elegans were grown under standard conditions (Lewis and Fleming, 1995) . Germ line transformation was performed by microinjection with pRF4 containing rol-6(su1006) as a transformation marker (100 ng/ml) with gfp reporters (10 ng/ml) (Mello and Fire, 1995) . The following strains were used in these studies: OK0592 cuIs23[Ptbx-2::gfp] III, OK0969 rrf-3(pk1426) II; cuIs23 III (Simmer et al., 2002), OK0029 cuIs1[ceh-22::gfp] (Okkema et al., 1997) , OK0041 cuIs3[8xB207::Δpes-10::gfp] (Okkema and Fire, 1994) , VC763 nfya-1(ok1174) X (provided by International C. elegans Gene Knockout Consortium), OK0971 cuIs23; nfya-1 (ok1174) X, OK0660 tbx-2(bx59) (Huber et al., 2013) The chromosomally integrated Ptbx-2::gfp reporter OK0592 [cuIs23 III] bearing pOK206.33+pRF4 was derived from OK0551 cuEx482 following EMS mutagenesis and was outcrossed twice to N2 (Anderson, 1995; Roy Chowdhuri et al., 2006) . The tbx-2 promoter fragment in pOK206.33 contains 3787 bp upstream of the tbx-2 ATG (bp 5139,963-5136,174 of LGIII, accession NC_003281.10) inserted in-frame into the gfp plasmid pOK95.69 (provided by A. Fire, Stanford University). For crossing cuIs23 into mutant backgrounds, multiplexed, single-worm PCR was used to genotype animals for rrf-3(pk1426) using primers PO848 [TTCTGCGATTGCGATTGG] Okkema, 2004) . tbx-2(bx59) disrupts a BstCI restriction site, and animals were genotyped for this allele as described previously (Huber et al., 2013) .
General methods for nucleic acid manipulations and plasmid construction
Standard methods were used to manipulate plasmid DNAs and oligonucleotides (Ausubel, 1990) , and all plasmid sequences are available from the authors. CCAAT-boxes at À 3609 and À245 (bp 5139738-5139743 and 5136375-5136379, respectively, in LGIII, accession NC_003281.10) using the Stratagene QuikChange II Kit in the Ptbx-2::gfp plasmid pOK206.33 (Roy Chowdhuri et al., 2006) to produce Ptbx-2 prox ::gfp plasmid pOK255.07 and Ptbx-2 dist ::gfp plasmid pOK255.08, respectively, and the double mutant Ptbx-2 prox+dist ::gfp plasmid pOK270.06 was constructed from these plasmids using standard ligation. All plasmids were sequenced to verify the presence of the mutations.
RNAi analyses
The RNAi feeding screen was modified from Kamath and Ahringer (2003) . E. coli strains for feeding RNAi of transcription factor genes were recovered from the C. elegans RNAi feeding library and the Transcription Factor sub-set (MRC Geneservice) (Kamath and Ahringer, 2003; Reece-Hoyes et al., 2005) , and feeding RNAi was performed on OK0592 cuIs23[Ptbx-2::gfp] III or in the RNAi hypersensitive strain OK0969 rrf-3(pk1426) II; cuIs23 III at 20 1C or 16 1C, respectively. Briefly, L4 hermaphrodites were plated seeded RNAi plates for 24 h transferred to freshly seeded RNAi plates, and removed after 1-3 days. The F1 progeny were scored for lethality and morphological abnormalities, and for alterations in Ptbx-2::gfp expression using a Leica MZ FLIII fluorescence dissecting microscope and a Zeiss Axioskop compound microscope.
RNAi analyses using injection of double-stranded RNA were performed essentially as previously described (Fire et al., 1998) . dsRNA produced by vitro transcription (Ambion) of cDNAs from nfya-1 (yk468e11/pOK296.01), nfya-2 (yk635h6/pOK296.03), nfyb-1 (yk401d5/pOK296.05), nfyc-1 (yk232h5/pOK296.07), and tbx-2 (yk112c4/pOK165.07) provided by Y. Kohara (National Institute of Genetics, Japan) was injected into Ptbx-2::gfp containing strains at approximately 200-500 ng/ml at 20 1C. Injected animals were transferred to fresh plates every 12 h, and animals laid 24-48 h post injection were scored for altered Ptbx-2::gfp expression.
Quantification of mRNA levels using real-time PCR Synchronized N2 and nfya-1(ok1174) L1 larvae were prepared by bleaching mixed-stage animals and allowing the isolated embryos to grow 12 h on OP50 seeded NGM plates at 20 1C (Lewis and Fleming, 1995) . Total RNA was isolated using TRIzol (Invitrogen), and purified using the RNeasy Mini Kit (Qiagen) and the TURBO DNA-free kit (Ambion) according to manufacturers' instructions. Reverse transcription and real-time PCR was performed using 100 ng total RNA and the Power SYBR Green RNA-toCt 1 step kit (Invitrogen) in an ABI 7500FAST PCR thermocycler (Applied Biosystems). Three to four replicates were performed for each RNA sample, and three independent RNA samples were assayed for each genotype. Exonic primers that spanned introns in tbx-2 (PO1048 [TCAAAACGAGAAGGTGACGG]; PO1072 [ATGTGT GGGTAGTGAAGCGG]) and ama-1 (PO1061 [AGGCGAAGGATGTGTT GTG]; PO1062 [TCACCGTGTTCTTTGGGTC]) were used, and the level of tbx-2 expression relative to that of ama-1 was compared in N2 and nfya-1(ok1174) animals using the 2 À ΔΔCt method (Livak and Schmittgen, 2001 ).
Isolation, mapping and identification of nfyb-1(cu13) cu13 arose spontaneously in the tbx-2(bx59) background and was outcrossed with wild-type N2. Self-progeny of cu13/+; tbx-2 (bx59)/+ heterozygotes were recovered at 16 1C. Five percent of these isolated strains exhibited highly penetrant L1 arrest when shifted to 25 1C (n ¼ 119). Animals homozygous for unlinked alleles are expected to arise at a frequency of 6.25%, indicating cu13 is an unlinked, recessive enhancer of tbx-2(bx59). SNP mapping using the polymorphic strain CB4856 indicated cu13 maps on LGII left of pkP2103 (LGII bp 3828,608) (Davis et al., 2005) . To outcross cu13 from the tbx-2(bx59) background, progeny of cu13++/+ dpy-10 (e128) unc-4(e120); tbx-2(bx59)/+ animals were picked to individual plates and screened for animals that lacked the tbx-2(bx59) allele by PCR and that segregated 100% non-Dpy non-Unc progeny. This strain OK0814 was verified to be homozygous for cu13 by crossing back into tbx-2(bx59) and recovering animals exhibiting the enhanced L1 arrest phenotype.
Illumina paired-end sequencing was used to sequence genomic
, and N2, and we obtained 59-to 79-fold coverage for each genome. Sequences were aligned to the reference C. elegans genome (WS220; www.wormbase.org) using Bowtie 2 (Langmead and Salzberg, 2012) , and SNP/INDEL variants were identified using the SAMtools package (Li et al., 2009) . Variants were annotated with ANNOVAR software (Wang et al., 2010) using genome annotatons retrieved from the USCS Genome Broswer (ce10/WS220). Variants were compared between genomes using Microsoft Access, and variants and the underlying sequence reads were visualized using the Integrative Genomics Viewer (IGV) (Thorvaldsdottir et al., 2012) . No SNP/INDELs affecting coding sequences on LGII specifically in the OK0661 and OK0814 genomes were found. To identify deletions, base calls for LGII output from Bowtie 2 SAM files were directly entered into a Microsoft Access database, and regions of low sequence coverage in the OK0661 and OK0814 were manually examined using the IGV. cu13 is a 5116 bp deletion/1 bp insertion (A/T) that removes bp 460,880-465,995 of LGII (WS220).
Microscopy
Worms were visualized using Zeiss Axioskop and AxioImager microscopes equipped for DIC and fluorescence microscopy, and images were captured using an Axiocam MRm camera and AxioVision or Zen 2011 software.
Results nfyc-1 negatively regulates Ptbx-2::gfp expression tbx-2 is expressed in a dynamic pattern throughout the C. elegans life cycle, and we are interested in identifying mechanisms that regulate tbx-2 expression. We have previously described a tbx-2::gfp promoter fusion that contains approximately 3.7 kb of tbx-2 5′-flanking DNA fused to the gfp coding sequence just downstream of the tbx-2 translational initiation site, and we subsequently refer to it as Ptbx-2::gfp ( Fig. 1A ) (Roy Chowdhuri et al., 2006) . In embryos, Ptbx-2::gfp was expressed in pharyngeal precursors beginning at the 100-200 cell stage, and GFP remained detectable in the pharynx until near hatching ( Fig. 1B and C) . During larval and adult stages Ptbx-2::gfp was strongly expressed in several neurons in the head and occasionally neurons in the tail, but it was not expressed in the pharynx or other tissues ( Fig. 1D-G) .
To identify mechanisms regulating tbx-2 expression, we used feeding RNAi to knock down expression of transcription factor genes in strains containing a chromosomally integrated Ptbx-2::gfp reporter and screened for changes in GFP expression (see Materials and Methods). We examined 725 of the 934 predicted transcription factor genes in the C. elegans genome (Supplemental Table 1 ) (Reinke et al., 2013) and found that RNAi knock down of two genes, nfyc-1 and tbx-2 itself, resulted in ectopic Ptbx-2::gfp expression in the gut. By comparison, no genes were identified whose knockdown eliminated Ptbx-2::gfp expression. In the remainder of this paper we focus on characterizing the role of nfyc-1 and related genes in tbx-2 regulation.
To more closely examine the effect of nfyc-1 knockdown, we examined Ptbx-2::gfp expression in nyfc-1(RNAi) animals produced by injecting double-stranded nfyc-1 RNA (Fire et al., 1998) . These nfyc-1(RNAi) animals exhibited ectopic GFP expression throughout the gut, as observed in the feeding RNAi screen, as well as in the seam cells, a group of hypodermal blast cells arranged as longitudinal rows on the lateral surface of the worm ( Fig. 2A and B) . In both tissues, ectopic Ptbx-2::gfp expression was limited to L4 and adult animals. These results suggest NFYC-1 represses tbx-2 promoter activity in seam and gut cells.
The NF-Y complex negatively regulates tbx-2 expression nfyc-1 encodes the C-subunit of the conserved heterotrimeric transcription factor NF-Y. In mammals, NF-Y is a ubiquitously expressed complex comprised of A, B, and C subunits (Mantovani, 1999) . In C. elegans, there are two distinct NF-Y complexes that share B and C subunits encoded by the nfyb-1 and nfyc-1 genes, respectively, but they contain different A subunits encoded by either nfya-1 or nfya-2 (Deng et al., 2007) . To ask if either NF-Y complex represses tbx-2 expression, we examined Ptbx-2::gfp in animals in which other NF-Y subunits were individually knocked down by RNAi. As in nfyc-1(RNAi) animals, Ptbx-2::gfp was ectopically expressed in seam cells and gut of nfya-1(RNAi) and nfyb-1(RNAi) animals in late larval stages through adulthood ( Fig. 2C-F) . In contrast, nfya-2(RNAi) animals exhibited only infrequent and faint expression in seam cells of the head, suggesting NFYA-2 plays only a minor role in repressing Ptbx-2::gfp expression (Fig. 3) . As a control to ask if NF-Y knockdown specifically derepressed Ptbx-2::gfp, we examined expression of two additional pharyngeal markers ceh-22::gfp and a myo-2 enhancer::gfp and found their expression was unaffected by nfyb-1(RNAi) (Okkema and Fire, 1994; Okkema et al., 1997) (data not shown). Together these results indicate the NF-Y complex containing NFYA-1 specifically represses Ptbx-2::gfp expression.
To further assess the specificity of the loss of NF-Y phenotype, we examined Ptbx-2::gfp expression in an nfya-1 null mutant ( Fig. 4A and B) . nfya-1(ok1174) homozygotes were viable but exhibited slow growth and male mating defects consistent with the phenotypes in previously described nfya-1 mutants (Deng et al., 2007) . Just as when NF-Y components were knocked down by RNAi, nfya-1(ok1174) mutants ectopically expressed Ptbx-2::gfp in seam cells and the gut ( Fig. 2G and H; Table 1 ). However, unlike our RNAi experiments, ectopic Ptbx-2::gfp expression in the gut of nfya-1(ok1174) mutants was detectable as early as the L1 stage ( Fig. 5A and B) . These results suggest that NF-Y regulation of tbx-2 expression occurs throughout larval development, and that nfya-1 (RNAi) is less effective in knocking out activity of the NF-Y complex than the null mutant.
Two CCAAT-boxes in the tbx-2 promoter are important for tbx-2 regulation NF-Y binds CCAAT-boxes, which are common eukaryotic regulatory sites typically found in promoters approximately 60 to 100 bp upstream of the transcriptional start site (Mantovani, 1999) . While the transcriptional start site for tbx-2 is not known, the tbx-2 promoter contains two CCAAT-boxes located at 3566 bp and 203 bp upstream of the translational start codon, and we refer to these as the distal and proximal sites, respectively (Fig. 1A) . To ask if these sites regulate tbx-2 promoter activity, we examined the effect of mutating them on Ptbx-2::gfp expression in multiple independent transgenic lines. A mutation of the proximal CCAATbox (Ptbx-2 prox ::gfp) resulted in very frequent ectopic GFP expression in seam cells and gut ( Fig. 6; Table 1 ). In comparison, a mutation of the distal CCAAT-box (Ptbx-2 dist ::gfp) resulted in much bracket; bp 11,944,734-11,946,570) that removes most of the nfya-1 coding sequence and introduces a frame-shift. (B) Schematic diagram of the NFYA-1 protein (accession NP_509999) indicating the HAP2 similarity domain (light gray box), which is necessary for complex formation and DNA-binding (Mantovani et al., 1994) . The NFYA-1 protein is predicted to be truncated upstream of the HAP2 domain after residue 55 in this mutant (gray circle). (C) Schematic diagram of the nfyb-1 genomic region numbered according to accession AF025470. Dark gray boxes indicate nfyb-1 exons and the direction of transcription. nfyb-1(cu13) is a 5116 bp deletion/1 bp insertion (bracket; bp 12,583-17,698) removing 5 exons and a portion of the 3′ UTR region. (D) Schematic diagram of the NFYB-1 protein (accession CCD65581) indicating the histone-fold domain (HFD) necessary for DNA binding (light gray box). The NFYB-1 protein is predicted to be truncated downstream of the HFD after residue 189 in this mutant (gray circle). less frequent ectopic GFP expression ( Fig. 6; Table 1 ). However Ptbx-2 dist ::gfp was expressed more frequently in seam cells and more widely throughout the gut than wild-type Ptbx-2::gfp, for which the occasional gut expression we observed was limited to posterior cells. A double mutant of both CCAAT-boxes (Ptbx-2 prox+dist ::gfp) was expressed similarly to the Ptbx-2 prox ::gfp single mutant in seam cells, but it was expressed less frequently in the gut than Ptbx-2 prox ::gfp (Table 1) . We conclude that the proximal CCAAT-box is the major site repressing Ptbx-2::gfp in the seam cells and gut. The distal site also plays a minor role in repressing Ptbx-2::gfp, but it may have an additional activating role, because the double CCAAT-box mutant had less frequent expression than the proximal mutant alone. Because both loss of NF-Y function and these CCAAT-box mutations lead to ectopic Ptbx-2::gfp expression in identical patterns, it is likely that NF-Y directly represses the tbx-2 promoter.
NF-Y represses endogenous tbx-2 expression
While NF-Y clearly represses Ptbx-2::gfp, we wanted to know if it regulates expression of the endogenous tbx-2 gene. tbx-2 mRNA levels in wild-type and nfya-1(ok1174) mutants were compared using quantitative real-time PCR. Because nfya-1(ok1174) larvae grow more slowly than wild type, we used total RNA isolated from synchronized L1 animals to avoid differences in mutant and wildtype populations resulting from these different larval growth rates. Ectopic Ptbx-2::gfp expression was first detectable in the guts of nfya-1(ok1174) L1s (Fig. 5B) , and we hypothesized that ectopic expression of endogenous tbx-2 expression would similarly begin at this stage. We found nfya-1(ok1174) mutants over-expressed tbx-2 1.40 7 0.07 fold relative to wild-type. While this difference is relatively small, it is highly significant (p ¼0.005), and it likely reflects the onset of ectopic tbx-2 expression. These results argue Fig. 5 . Ectopic Ptbx-2::gfp is expressed in early larvae in nfya-1(ok1174) and nfyb-1(cu13). Fluorescence (left) and DIC (right) images of wild-type (A), nfya-1(ok1174) (B), and nfyb-1(cu13) L1 larvae expressing Ptbx-2::gfp. Neuronal expression Ptbx-2::gfp is marked with arrowheads. Ectopic expression in representative gut nuclei is marked with arrows. that NF-Y represses expression of endogenous tbx-2 similarly to Ptbx-2::gfp.
An nfyb-1 mutation enhances the phenotype of a tbx-2 mutant tbx-2(bx59) is a temperature sensitive mutant exhibiting partially penetrant lethality and pharyngeal defects, and it provides a compromised genetic background that can be used to identify genes affecting tbx-2 activity (Huber et al., 2013) . We isolated a spontaneous mutation called cu13 that enhances tbx-2(bx59) lethality and, using SNP mapping and whole genome sequencing, we identified cu13 as an allele of nfyb-1 (Fig. 4C) (Davis et al., 2005; Sarin et al., 2008) . nfyb-1(cu13) is a 5116 bp deletion/1 bp insertion that removes the last 5 exons of this gene. Over 50% of the nfyb-1 coding sequence is deleted, and this deletion is predicted to truncate the NFYB-1 protein downstream of the histone fold domain (HFD) involved in DNA binding (Fig. 4D) . The endpoints of the cu13 deletion are located within tandem repeat sequences that are enriched in this region (Wormbase WS230), and these repeats likely contributed to formation of this deletion.
We out-crossed nfyb-1(cu13) from the tbx-2(bx59) mutant background and found that these nfyb-1(cu13) single mutants ectopically expressed Ptbx-2::gfp in a pattern identical to nfya-1 (ok1174) mutants. Nearly all nfyb-1(cu13) animals expressed Ptbx-2::gfp in seam cells and gut at the L4 and adult stages ( Fig. 2I and J ; Table 1 ). As in nfya-1 mutants, ectopic Ptbx-2::gfp expression was detectable in the gut as early L1 stage (Fig. 5C) , and it increased in strength and frequency the seam cells through larval development.
This unexpected finding of an nfyb-1 mutation as an enhancer of the tbx-2 mutant phenotype indicates NF-Y regulation is crucial for tbx-2 expression in vivo, and we compared the phenotype of nfyb-1(cu13); tbx-2(bx59) double mutants with those of tbx-2 (bx59) and nfyb-1(cu13) single mutants. When tbx-2(bx59) hermaphrodites were shifted to the non-permissive temperature, their progeny exhibited a partially penetrant L1 arrest phenotype (Huber et al., 2013) , and this phenotype was strongly enhanced by nfyb-1(cu13). Forty-four percent of tbx-2(bx59) animals arrested as L1 larvae, and most of the remaining animals grew to adulthood (Table 2; Table 3 ). In comparison, all nfyb-1(cu13); tbx-2(bx59) double mutants arrested as L1 animals, and none of these animals grew to adults. As with other NF-Y mutants (Deng et al., 2007) , no L1 arrest was observed in nfyb-1(cu13) single mutants, indicating the lethality in the double mutants results from enhancement of the tbx-2(bx59) phenotype.
tbx-2(bx59) single mutants exhibit variable pharyngeal defects (Huber et al., 2013) . Nineteen percent of these animals have a severe phenotype with a clear loss of ABa-derived pharynx, similar to that observed in tbx-2 null mutants (Roy Chowdhuri et al., 2006) . The remaining animals exhibit either moderate morphological defects (56%) or normal pharyngeal morphology (25%) (Huber et al., 2013) . We expected that the enhanced L1 arrest observed in nfyb-1(cu13); tbx-2(bx59) double mutants would result from increased severity of the pharyngeal defect. However, we did not find any nfyb-1(cu13); tbx-2(bx59) animals exhibiting the severe phenotype and a loss of ABa-derived pharynx. Rather nfyb-1(cu13); tbx-2(bx59) animals exhibited a moderate morphological defect in the pharynx (81%, n ¼ 28) at a frequency higher than tbx-2(bx59) single mutants (54%, n ¼26) (Fig. 7) . The fact that these pharyngeal defects were not enhanced indicates nfyb-1 (cu13); tbx-2(bx59) lethality did not result from eliminating tbx-2 expression in the pharynx. Table 2 Viability of tbx-2(bx59) and nfyb-1(cu13) mutants. Animals reaching L4 and adult stages were scored after 3 days.
Table 3
Effect of nfyb-1(RNAi) on tbx-2(bx59) and nfyb-1(cu13); tbx-2(bx59) mutants. Animals reaching L4 and adult stages were scored after 3 days. b Pooled data from embryos collected 12-16 and 24-27 h post-injection.
No differences were observed at these different time points.
Loss of nfyb-1 and tbx-2 function causes enhanced lethality
The synergistic phenotypes observed in nfyb-1(cu13); tbx-2 (bx59) double mutants argue that both of these genes function in the same pathway in vivo [see (Herman and Yochem, 2005) ]. However, we do not know whether these individual mutations result in gain-or loss-of-function. The region deleted in nfyb-1 (cu13) encodes no recognizable functional domains, and this allele could produce a deleted protein that retains the HFD (Fig. 4D) . tbx-2(bx59) is a missense mutation that substitutes a conserved histidine residue in the dimerization domain of the TBX-2 DNAbinding domain with tyrosine (H154Y; accession CC69847) (K. Chow, personal communication) (Huber et al., 2013) , and mutations affecting nearby residues in the dimerization domain of human TBX1 are gain-of-function mutations that underlie some cases of DiGeorge and velocardiofacial syndromes (Zweier et al., 2007) . To examine the nature of nfyb-1(cu13) and tbx-2(bx59) mutations we used RNAi to knock down activity of nfyb-1 or tbx-2 in either tbx-2(bx59) or nfyb-1(cu13) mutants, respectively, and in the nfyb-1(cu13); tbx-2(bx59) double mutant.
We predicted that if nfyb-1(cu13) was a loss-of-function allele, nfyb-1(RNAi) should increase lethality in tbx-2(bx59) mutants, whereas, if it was a gain-of-function allele, nfyb-1(RNAi) should suppress larval lethality in nfyb-1(cu13); tbx-2(bx59) double mutants. We observed a strongly enhanced larval lethal phenotype in nfyb-1(RNAi); tbx-2(bx59) double mutants compared to tbx-2 (bx59) or nfyb-1(RNAi) alone, and we saw no suppression of the larval lethal phenotype in nfyb-1(RNAi); nfyb-1(cu13); tbx-2(bx59) animals (Table 3 ). Thus we conclude that nfyb-1(cu13) is a loss-offunction allele, and that loss of nfyb-1 enhances the tbx-2(bx59) phenotype.
We similarly predicted that if tbx-2(bx59) was a loss-offunction allele, tbx-2(RNAi) would enhance the lethality of nfyb-1 (cu13) mutants, while, if it was a gain-of-function allele, tbx-2 (RNAi) would suppress lethality of nfyb-1(cu13); tbx-2(bx59) double mutants. Again we found that tbx-2(RNAi) strongly enhanced the larval lethality in the nfyb-1(cu13) background, while we saw no suppression of lethality in tbx-2(RNAi); nfyb-1(cu13); tbx-2 (bx59) animals (Table 4) . We also asked whether one functional allele of tbx-2 was sufficient for viability when nfyb-1 was reduced.
To investigate this, we tested if nfyb-1(RNAi) would enhance lethality in animals heterozygous for the tbx-2(ok529) null mutant. tbx-2(ok529) results in recessive L1 lethality, but tbx-2(ok529)/+ heterozygotes were completely viable (Roy Chowdhuri et al., 2006) . We examined the progeny of tbx-2(ok529)/+ hermaphrodites that had been injected with nfyb-1 dsRNA, but we did not see a difference in the number of viable, heterozygous tbx-2(ok529)/+ progeny segregating from animals either injected or non-injected control animals (n ¼ 412 and 401, respectively). Together these results indicate that tbx-2(bx59) is a hypomorphic, loss-of-function allele, and they suggest that, at the non-permissive temperature, tbx-2(bx59) mutants have less TBX-2 activity than tbx-2(ok529)/+ heterozygotes.
Discussion
Here we show that NF-Y is a tissue-and stage-specific repressor of C. elegans tbx-2 gene expression. Loss of NF-Y leads to ectopic expression of Ptbx-2::gfp in the seam cells and gut of larvae and adults and increased expression of endogenous tbx-2. NF-Y repression of tbx-2 is likely to be direct, as both loss of NF-Y and mutation of CCAAT-boxes within the tbx-2 promoter lead to nearly identical patterns of ectopic Ptbx-2::gfp expression. Finally the fact that an nfyb-1 mutation enhances the lethal phenotype of a hypomorphic tbx-2 mutant argues that NF-Y repression is crucial for normal tbx-2 function in vivo.
C. elegans NF-Y represses transcription
CCAAT-boxes are common eukaryotic regulatory sequences, found near the transcription start site in approximately 12% of human promoters (Dolfini et al., 2009 ). The conserved NF-Y complex is the major CCAAT-box binding factor and NF-Y binding is typically associated with transcriptional activation (Mantovani, 1999) . However, examples of transcriptional repression are also known (Buschlen et al., 2003; Ceribelli et al., 2008) . Genome wide characterization of NF-Y targets has not been carried out in invertebrate model organisms. However, characterization of the Drosophila p53 and sevenless genes indicates that NF-Y can function as an activator in this organism (Tue et al., 2011; Yoshioka et al., 2012) .
C. elegans NF-Y has only begun to be characterized, but, in the few known examples, it functions as a transcriptional repressor. As we have found for tbx-2, expression of the Hox genes egl-5 and Fig. 7 . Pharyngeal morphology is similar in tbx-2(bx59) and nfyb-1(cu13); tbx-2 (bx59). DIC micrographs of the pharynxes of L1 animals: (A) wild type; (B) a moderately affected tbx-2(bx59) animal; (C) an nfyb-1(cu13); tbx-2(bx59) double mutant. The procorpus (arrowhead) and the metacorpus (arrow) consisting primarily of ABa-derived pharyngeal muscles are marked. These regions are present but morphologically abnormal in tbx-2(bx59) and nfyb-1(cu13); tbx-2 (bx59) mutants.
Table 4
Effect of tbx-2(RNAi) on nfyb-1(cu13) and nfyb-1(cu13); tbx-2(bx59) mutants. Animals reaching L4 and adult stages were scored after 3 days. b Pooled data from embryos collected 12-16 and 24-27 h post-injection.
mab-5 is repressed by NF-Y (Deng et al., 2007) . This repression is tissue-specific, and loss of nfya-1 or mutation of a CCAAT-box in the egl-5 promoter leads to ectopic egl-5::gfp expression in seam cells and elsewhere in the hypodermis. This incomplete overlap with the tissues where Ptbx-2::gfp is repressed suggests the specific mechanisms by which NF-Y represses tbx-2 and egl-5 are distinct. Indeed, NF-Y interacts with the MES-2/MES-6 PcG complex to repress egl-5, but we have not observed a role for MES-2/ MES-6 in repressing tbx-2 expression. At this point, it is not known what other genes NF-Y regulates in C. elegans, or whether C. elegans NF-Y can activate as well as repress transcription. Indeed, our work suggests the distal CCAATbox in Ptbx-2::gfp weakly activates expression, implying NF-Y can both repress and activate transcription. While C. elegans NF-Y subunits are conserved with those in mammals, they do have some interesting differences that might affect their activities. For example, C. elegans NFYC-1 lacks a glutamine-rich transcriptional activation domain found in mammalian NF-YC subunits (Coustry et al., 1996; Deng et al., 2007) . This difference suggests that C. elegans NF-Y may not be as strong an activator as mammalian NF-Y, or that it activates transcription with co-activators, as has been observed with the yeast HAP complex (Olesen and Guarente, 1990) . In another example, C. elegans NFYA-1 contains a G to D substitution converting the highly conserved GXGGRF motif to GXDGRF. In human NF-Y, this affected G directly contacts the a base in the CCAAT box (Nardini et al., 2013) , and the G to D substitution could affect NF-Y binding affinity or specificity. Interestingly NFYA-2 contains an XGGRF more similar to the motif in human NF-YA, and these differences suggest the NF-Y complexes containing NFYA-1 or NFYA-2 may target different sites in the genome. Additional work will be necessary to identify more C. elegans NF-Y targets, and determine if NF-Y can activate transcription in this organism.
Ptbx-2::gfp expression is specifically repressed in seam cells and the gut C. elegans NF-Y is broadly expressed, yet loss of NF-Y regulation results in Ptbx-2::gfp expression only in the seam cells and gut. This suggests that the tbx-2 promoter is poised for expression in these tissues. Seam cells and gut are derived from different germ layers and are lineally unrelated (Sulston et al., 1983) . However, these tissues share the common feature that they undergo DNA replication each larval stage. Seam cells replicate DNA and divide in a stem cell-like pattern near the end of each stage, producing one differentiated daughter and one seam cell daughter (Joshi et al., 2010) , and gut cells replicate DNA and undergo either a nuclear division or endoreduplication at each larval stage (Hedgecock and White, 1985) . Perhaps C. elegans tbx-2 is primed for low level or transient expression in seam cells and gut to promote DNA replication, but NF-Y represses expression to undetectable levels under most circumstances.
Mammalian TBX2 and TBX3 are orthologs of C. elegans tbx-2, and they function as regulators of cell cycle progression and as inhibitors of cellular senescence [reviewed in (Lu et al., 2010) ]. Interestingly, they are both believed to be activated by NF-Y (Smith et al., 2011; Teng et al., 2008) . Although this regulation is different from what we have observed for C. elegans tbx-2, it shows NF-Y is a regulator of T-box gene expression in very different species.
NF-Y affects tbx-2 activity in vivo
Our finding that the spontaneous mutant nfyb-1(cu13) enhances lethality of tbx-2(bx59) demonstrates NF-Y plays an important role in regulating tbx-2 activity in vivo. However the mechanism by which loss of NF-Y regulation enhances tbx-2(bx59) lethality is unclear. Because nfyb-1(cu13) is viable in a tbx-2(+) background, simple loss of repression resulting in expression of tbx-2 in seam cells and gut would not explain the enhanced lethality in nfyb-1(cu13); tbx-2(bx59) double mutants. One possibility is that NF-Y and TBX-2 have partially overlapping functions regulating other downstream genes, and loss of both TBX-2 and NF-Y regulation leads to lethality in nfyb-1(cu13); tbx-2(bx59) mutants. Alternatively, mutations in nfyb-1 and tbx-2 may lead to even higher levels of tbx-2 overexpression than nfyb-1 mutants alone. We identified tbx-2 in our RNAi screen as a potential negative regulator of Ptbx-2::gfp, and we are currently investigating whether NF-Y and TBX-2 function in parallel to repress the tbx-2 promoter.
Like our observations with nfyb-1, other genetic modifiers of T-box gene mutants reveal important mechanisms regulating T-box gene expression and activity. C. elegans TBX-2 is posttranslationally modified by SUMOylation, and we have shown that reducing SUMOylation enhances the tbx-2(bx59) phenotype (Huber et al., 2013) . Likewise reducing the mouse MOZ histone acetyltransferase enhances defects resulting from haploinsufficiency of Tbx1, and it is suggested that the epigenetic regulatory state of human TBX1 contributes to the variable severity of symptoms observed in DiGeorge syndrome patients (Voss et al., 2012) . Characterization of additional modifiers of T-box gene mutations will likely continue to provide novel insights into Tbox factor function.
